Zagotenemab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Zagotenemab is targeting TAU protein, and it has launched a phase II clinical trial in April 2018.
Zagotenemab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Zagotenemab is targeting TAU protein, and it has launched a phase II clinical trial in April 2018.
Read more ...